Four Spanish Biotech Companies considering listing at Euronext

04/10/2018

Imagen Noticia

Euronext, Pan-European operator of stock exchanges and capital markets platform, has presented the fourth edition of TechShare, a program aimed at facilitating the process of going public of unlisted companies.

This latest edition of TechShare has included for the first time 4 Spanish biotech companies: Histocell, Mynorix, Ability Pharma and SOM Biotech.

Launched in 2015, TechShare is a unique pan-European programme that helps to familiarise innovative businesses with capital markets and give them all the information they need to reach the next stage of their growth and take their companies to market. Selected for their innovative flair and impressive performance, participants are businesses active in digital technology, life sciences and eco-industries that might consider listing in the three years ahead.

#Cross-sectorial